Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLAS tamoxifen duration trial in early breast cancer
ACTRN12606000533594Phase 3Completed
- Sponsor
- Breast Cancer Trials
- Start
- Jul 1996
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of tamoxifen in breast cancer (2 arms), sponsored by Breast Cancer Trials. Primary endpoints: All-cause mortality, Cause-specific mortality and 1 more. Started Jul 1996; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12606000533594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000533594.